Veradermics, Inc

MANE · NYSE · SIC 2834: Pharmaceutical Preparations
5
SEC Filings

Business Summary

PART I Overview We are a dermatologist-founded, late clinical-stage biopharmaceutical company, or the Company, we, us, or our, focused on developing innovative therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. Our initial focus is developing better treatments for PHL, a condition affecting approximately 50 million men and 30 million women in the United States. Current PHL treatment options are limited and therefore are consistentl...

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionMANEdiscussed_in_filing Cybersecurity
topic_mentionMANEdiscussed_in_filing Trusted Computing
topic_mentionMANEdiscussed_in_filing Blockchain & Crypto
topic_mentionMANEdiscussed_in_filing Capital Expenditure
topic_mentionMANEdiscussed_in_filing Regulation
topic_mentionMANEdiscussed_in_filing Healthcare & Bio
topic_mentionMANEdiscussed_in_filing Cybersecurity
topic_mentionMANEdiscussed_in_filing Trusted Computing
topic_mentionMANEdiscussed_in_filing Blockchain & Crypto
topic_mentionMANEdiscussed_in_filing Capital Expenditure
topic_mentionMANEdiscussed_in_filing Regulation
topic_mentionMANEdiscussed_in_filing Healthcare & Bio
topic_mentionMANEdiscussed_in_filing Cybersecurity
topic_mentionMANEdiscussed_in_filing Trusted Computing
topic_mentionMANEdiscussed_in_filing Blockchain & Crypto
topic_mentionMANEdiscussed_in_filing Capital Expenditure
topic_mentionMANEdiscussed_in_filing Regulation
topic_mentionMANEdiscussed_in_filing Healthcare & Bio
topic_mentionMANEdiscussed_in_filing Cybersecurity
topic_mentionMANEdiscussed_in_filing Trusted Computing

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-302025-12-310001827635-26-000013EDGAR110K words

Quarterly Reports (10-Q)

No 10-Q filings indexed.

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-300001827635-26-000010EDGAR3K words
2026-02-050001628280-26-005800EDGAR—

5 total filings indexed. 2 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001827635
TickerMANE
ExchangeNYSE
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 7a89b2e8e3519c70b00e07843be79a50e2184fadd74a0a680ff00f324719dd32
parent: 1cdc9b0a7d982e2601cec5ca9b3ad9113cd68da477f1174feb48c904fb0ab2d4
content hash: e85e58cb8cb36bd4ed242fae165fdb9209f13620a8481ca1daadc5c1066aa980
signed: 2026-04-13T04:46:09.853Z
sources: 1 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf